August 2018
Table of Contents

Funding Opportunities

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)


Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)


Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)


Multiple CDMRP FY18 Funding Opportunities



View a full list of current funding opportunities.

Highlighted positions related to cancer for which VCU is currently hiring. View the full list.




Program Co-Leader, Cancer Molecular Genetics (F36090)


Surgical Oncology Division Chair (F59750)

Shared Resource Spotlight
Cancer Informatics Core

The Cancer Informatics Core facilitates biomedical and translational research by providing methods and tools to record, integrate, manage, analyze and visualize various biomedical, behavioral and clinical data. Available services include consultation, data integration and honest broker services, feasibility assessment, cohort identification, clinical annotation, dataset and report development, electronic data capture and bioinformatics support. These services rely on the CIC Universal Data Store, which consists of consolidated and linked data from VCU Health System's various clinical-related data systems. 


To request a CIC service, except for Bioinformatics, fill out a CIC Service Request Form.


To request Bioinformatics services, fill out a Massey Bioinformatics Service Request Form.


For more information, contact core director, Tamas Gal, Ph.D., at 628.2123 or

Leaders' Update Update 
A message from Deputy Director Steven Grossman

Dear colleagues,

Identifying novel therapeutics arising from Massey science is of the highest priority for Massey Cancer Center. To that end, Dr. Steve Grant and I are are spearheading the establishment of a formalized process that supports a translational pipeline for drug development at Massey.

This message continues with more about the efforts underway to develop the first Massey born and raised cancer drug.

Research HighlightsHighlights
Study shows palliative care associated with shorter hospitalizations and reduced medical costs
Brian Cassel, Ph.D.
Cancer Prevention and Control member
Developmental Therapeutic member

Palliative care consultations  administered within three days of admission are linked to shorter hospitalizations and significant cost savings for chronically ill adults, according to a large  meta-analysis study  co-authored by Egidio Del Fabbro and Brian Cassel. These findings, recently published in JAMA Internal Medicine , indicate that the greatest cost reduction attributed to palliative care  was  seen among cancer  patients.

Protein involved in milk production during pregnancy identified as potential target for novel breast cancer therapies
Charles Clevenger, M.D., Ph.D.
Cancer Cell Signaling member
Massey research led by Charles Clevenger discovered that the enzyme cyclophilin A regulates the Jak2/Stat5 genetic pathway, which is responsible for the natural maturation of mammary glands as well as the development of breast cancer cells. Published in Cancer Research, t his study identifies cyclophilin A as a relevant target for therapeutic intervention in breast cancer. Clevenger will continue to conduct further studies in pre-clinical models.

Center News Center1
Research Retreat features promising cancer research at VCU

In June, VCU researchers came together for Massey's annual Cancer Research Retreat. Presentations were given by Massey researchers Paul Dent, Vanessa Sheppard, Seth Corey and Mario Acunzo, with the keynote lecture delivered by Channing Der from UNC Lineberger Comprehensive Cancer Center. More then 65 students and postdoctoral fellows  participated in the afternoon poster session.

Massey first in the region to use a new device that marks breast tumors for removal

Massey is the first in the region to use a new, FDA-approved device called Magseedā„¢ that guides surgeons in locating and removing breast tumors as an alternative to wire localization. Magseedā„¢ is a magnetic seed made of stainless steel that can be placed  in the tumor at anytime. S tudies have shown that surgical outcomes  are better with the seed than  with  wire localization.

Member Showcase MemberShowcase

Thomson evaluates behavioral trends to integrate effective cancer prevention and healthy lifestyle strategies

Cancer Prevention and Control member
Maria Thomson joined Massey as a member of the Cancer Prevention and Control research program in 2017. She studies patient and caregiver decision-making as a means to streamline cancer prevention and healthy lifestyle interventions into the standard course of clinical care. Thomson is an assistant professor in the Department of Health Behavior and Policy.

Researcher Recognition Recognition
Faber named program leader of Developmental Therapeutics

Developmental Therapeutics co-leader
Massey researcher Anthony Faber has been appointed as the co-leader of the Developmental Therapeutics research program. He will serve in this capacity alongside Steven Grant, who has co-led the program since 2011. In this role, he will work with Grant to strengthen the program's membership, facilitate transdisciplinary collaboration among its members, cultivate its cancer-focused 
grant funding and foster  translational 
research leading to new clinical trials.

EventsUpcoming Events

Cancer Research Seminars
September 19, 2018: Wendy Demark-Wahnefried, Ph.D., of the UAB Comprehensive Cancer Center, will lead a seminar from 4-5 PM in GRL-131.
Swim Across America Richmond Open Water Swim

For a full listing of events, 

mediaMassey in the Media

NewsTop Cancer News
Share with us your research, awards and accomplishments!
Submit your news to Blake Belden at or (804) 628-4578.

Archived newsletters can be found here:
  Connect with us!
Join Massey's online communities.
Like us on Facebook
Follow us on Twitter
View our videos on YouTube